36 results
8-K
EX-99.1
u9rf2yc18mk350391z
10 Nov 22
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2022
4:13pm
424B5
5txma3ymc
4 Aug 22
Prospectus supplement for primary offering
4:52pm
424B5
rfson xi4y422reqrw3e
3 Aug 22
Prospectus supplement for primary offering
4:05pm
S-3
v9y g9aabkwj9cyg
13 Aug 21
Shelf registration
4:13pm
10-K
iv4exmoh9tiwiud3
11 Mar 21
Annual report
4:11pm
10-K
EX-4.6
4xw49qt
11 Mar 21
Annual report
4:11pm